The Pharmacokinetics and Viral Activity of Tenofovir in the Male Genital Tract
Manoli Vourvahis(Pfizer (United States)), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Ya-Chi Chen, James F. Rooney(Gilead Sciences (United States)), Hiba L. Tappouni(GlaxoSmithKline (Netherlands)), James Hoi Po Hui(National University of Singapore), Naser L. Rezk(University of North Carolina at Chapel Hill), Kristine B. Patterson(University of North Carolina at Chapel Hill), Brian P. Kearney(Belfast Health and Social Care Trust), Susan A. Fiscus(University of North Carolina at Chapel Hill), Myron S. Cohen(University of North Carolina at Chapel Hill)
Cited by 48
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817